Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort

Authors

Maximilian Filzmayer (ORCID: https://orcid.org/0009-0005-5715-9965)
Benedikt Lauer
Lena Theißen (ORCID: https://orcid.org/0000-0001-6791-8105)
Maximilian C. Kriegmair (ORCID: https://orcid.org/0000-0002-0344-3590)
Carolin Siech
Benedikt Hoeh (ORCID: https://orcid.org/0000-0002-4238-6584)
Quynh Chi Le (ORCID: https://orcid.org/0009-0008-9209-8776)
Felix K.-H. Chun
Markus Graefen
Thomas Steuber
Philipp Mandel
Hans Heinzer

Institutions

Goethe University Frankfurt (DE)
Universität Hamburg (DE)
Heidelberg University (DE)
University Hospital Heidelberg (DE)
University Medical Center Hamburg-Eppendorf (DE)
Martini-Klinik (DE)
University Hospital Frankfurt (DE)
University Medical Centre Mannheim (DE)
Urologische Klinik München (DE)

Publication Details

Journal: BMC Cancer
Published: 2026-03-02
DOI: https://doi.org/10.1186/s12885-026-15803-y
Primary Topic: Prostate Cancer Treatment and Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort

Maximilian Filzmayer, Benedikt Lauer, Lena Theißen, Maximilian C. Kriegmair et al.

Mar 2, 2026

BMC Cancer

Prostate Cancer Treatment and Research

article

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort

Maximilian Filzmayer, Benedikt Lauer, Lena Theißen, Maximilian C. Kriegmair, Carolin Siech, Benedikt Hoeh, Quynh Chi Le, Felix K.-H. Chun, Markus Graefen, Thomas Steuber, Philipp Mandel, Hans Heinzer

March 2, 2026article en

Abstract

No abstract available for this paper.

BMC Cancer

Goethe University Frankfurt (DE), Universität Hamburg (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), University Medical Center Hamburg-Eppendorf (DE), Martini-Klinik (DE), University Hospital Frankfurt (DE), University Medical Centre Mannheim (DE), Urologische Klinik München (DE)

Good health and well-being

Openalex Percentile: Top 37%

Prostate Cancer Treatment and Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort — Maximilian Filzmayer, Benedikt Lauer, et al. · BMC Cancer (2026) | TGRS Research Map | TGRS